Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
54 studies found for:    "Patent ductus arteriosus"
Show Display Options
RSS Create an RSS feed from your search for:
"Patent ductus arteriosus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Conditions: Patent Ductus Arteriosus;   Surgery;   Necrotizing Enterocolitis;   Intestinal Perforation
Interventions: Other: pharmacologic treatment of the PDA;   Other: no pharmacologic treatment of the PDA
2 Unknown  Treating the Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Pentoxifylline
3 Completed Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Ibuprofen
4 Recruiting Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen;   Drug: Placebo
5 Completed Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen EchoG;   Drug: Standard ibuprofen treatment
6 Unknown  Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
Conditions: Prematurity of Fetus;   Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Procedure: Surgical Ligation
7 Unknown  An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Indomethacin
8 Not yet recruiting Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants
Condition: Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants
Interventions: Drug: Paracetamol;   Drug: Placebo
9 Recruiting Paracetamol and Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol;   Drug: NSAID;   Drug: D5W
10 Active, not recruiting Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
11 Completed Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Device: Occlutech PDA occluder
12 Completed Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: oral ibuprofen;   Drug: intravenous ibuprofen
13 Completed Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Drug: indomethacin (two different dosing regimens)
14 Completed Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Intervention: Drug: Oral Ibuprofen
15 Completed
Has Results
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
Condition: Patent Ductus Arteriosus (PDA)
Interventions: Device: Device closure with AMPLATZER Duct Occluder;   Other: Objective Performance Criteria
16 Completed The Use of B-Type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
Conditions: Indomethacin Therapy;   Patent Ductus Arteriosus
Intervention: Procedure: Withhold standard INDO dose if BNP < 100 pg/ml
17 Recruiting Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
18 Completed Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
19 Active, not recruiting
Has Results
AMPLATZER Duct Occluder II Clinical Study
Condition: Patent Ductus Arteriosus
Intervention: Device: AMPLATZER Duct Occluder II
20 Completed Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
Condition: Patent Ductus Arteriosus
Interventions: Drug: Continuous indomethacin;   Drug: ibuprofen

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years